Structural and functional basis of cyclooxygenase inhibition.
about
Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxenDifferential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acidDevelopment of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven ReviewRoles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic ApproachesAnti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular DiseasesThe Structural Basis of Endocannabinoid Oxygenation by Cyclooxygenase-2The structure of NS-398 bound to cyclooxygenase-2Crystal Structures of Three Classes of Non-Steroidal Anti-Inflammatory Drugs in Complex with Aldo-Keto Reductase 1C3Investigating Substrate Promiscuity in Cyclooxygenase-2: THE ROLE OF ARG-120 AND RESIDUES LINING THE HYDROPHOBIC GROOVEExploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxibPrediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling.Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase InhibitorConservative Secondary Shell Substitution In Cyclooxygenase-2 Reduces Inhibition by Indomethacin Amides and Esters via Altered Enzyme Dynamics.Aspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis.Melatonin Ameliorates The Production of COX-2, iNOS, and The Formation of 8-OHdG in Non-Targeted Lung Tissue after Pelvic Irradiation.2-(2-Arylphenyl)benzoxazole As a Novel Anti-Inflammatory Scaffold: Synthesis and Biological EvaluationJeju seaweeds suppress lipopolysaccharide-stimulated proinflammatory response in RAW 264.7 murine macrophages.In situ click chemistry generation of cyclooxygenase-2 inhibitors.Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids.Inhibition of COX-2 and PGE2 in LPS-stimulated RAW264.7 cells by lonimacranthoide VI, a chlorogenic acid ester saponin.Cyclooxygenases: structural and functional insights.Synthesis of oligo(ethylene glycol) substituted phosphatidylcholines: secretory PLA2-targeted precursors of NSAID prodrugsCyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold.Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenograftsStraightforward protocol for the efficient synthesis of varied N(1)-acylated (aza)indole 2-/3-alkanoic acids and esters: optimization and scale-up.The structure of ibuprofen bound to cyclooxygenase-2.Nitroarachidonic acid, a novel peroxidase inhibitor of prostaglandin endoperoxide H synthases 1 and 2.Mechanistic insights into a classic wonder drug--aspirin.Flavocoxid inhibits phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidantPET radiotracer [¹⁸F]-P6 selectively targeting COX-1 as a novel biomarker in ovarian cancer: preliminary investigation.Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors.Human cyclooxygenase-1 activity and its responses to COX inhibitors are allosterically regulated by nonsubstrate fatty acids.Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1.Cyclic Dipeptide Shuttles as a Novel Skin Penetration Enhancement Approach: Preliminary Evaluation with DiclofenacAnti-inflammatory effects of bangpungtongsung-san, a traditional herbal prescriptionPotent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry.The lack of aspirin resistance in patients with coronary artery diseaseInhibitory effects of traditional herbal formula pyungwi-san on inflammatory response in vitro and in vivo
P2860
Q24621123-4AE901D6-6EC6-42F6-8509-1D125E6475FEQ24657423-928E95A6-9B51-4632-B92A-F677FFB29F60Q26750933-094596F0-97A2-4E2C-BE69-9863A9FBFC1EQ26752576-E4D50F41-686E-476E-9D50-EDC4221D6CB5Q26767400-3EC95A4E-37EF-41F0-B46A-9331A41BA349Q27667504-BE4848FC-0A01-416D-B152-A3358F18DE59Q27671771-AF6A2AC5-6C9C-444B-8D9A-5C478A7E64EFQ27671816-50D93BB1-F3BA-4679-99B6-B2C02A47328FQ27679318-DDC69E3B-AD3A-4D0F-8491-175B51A10074Q27680024-9DD0DAC7-D364-424D-891E-40B7F07E1ACDQ27902278-9FAABAEA-A1CB-4C58-B7EE-B1BB5FAEADBBQ28548509-71BF1F7D-69B1-400A-819E-22342C69753FQ30699848-E77DFE08-66D5-4A97-BB5A-0A1C76499359Q30841754-0B46279F-CC6D-4821-BC83-327FE1E19AC4Q33625832-364F91F9-CA8C-40BE-A3AE-9E952EA9EC6DQ33636453-E1300E37-A529-4086-B33C-D11C31FFD83EQ33657540-CCFBDF94-5A3B-409E-A859-D00680986974Q33687262-6028C6A1-7E13-4478-8566-C2D033DCBC64Q33890830-D678B540-D6FB-423A-BF4E-A338E379010EQ33932290-EAF0E80B-91CF-4EA5-9998-9F98E6B60B22Q34014369-C6A2E861-0EF3-4DDC-8585-7F6D175D278FQ34081569-A32375B4-73AC-4747-8702-E64C48295AF8Q34134282-C76363B6-25AE-4CE8-82BF-029F67F10C50Q34487087-C9985A74-2590-46A2-BEA2-14B383861613Q34498106-AFEB096A-48FD-4B1D-8F99-55FC5445ABB8Q34772023-A2A86DBE-8CA1-46A0-A654-E8B0B94544DFQ34787024-B85C118B-353B-4BBC-853A-C9D9E431DEAFQ35021715-00F0910B-6DBD-4D62-B3AD-99120CA8F523Q35098944-89EA76B2-41B3-41E1-812C-53106F655591Q35169525-EA55BC73-17CC-425E-AE8D-85A39F9D4ECFQ35660108-8B9DF749-A6C7-4876-B7ED-6F988DD389B8Q35737180-D5954674-79C4-4226-9056-D38DC11E8C24Q36020274-FE0E05F9-BDA8-4EAD-BE5F-198E69E97105Q36035412-61CC30BE-CAF8-469B-9E0E-C7DE5FCA0B0BQ36109341-D1F60103-DB8A-4300-AD61-FAF71B83B6E6Q36148576-6EF50999-5354-4B16-864E-24A54220B354Q36576347-9FF35F8F-098D-4F8F-A275-C82D64C33991Q36642779-2D1BCDA4-1635-4FE4-B68D-F38FFA539CE3Q36691432-323BB5C7-9FE7-4315-A7B6-05E3BD7E112DQ36711577-A69245A8-AD91-4747-9761-0D62E426D538
P2860
Structural and functional basis of cyclooxygenase inhibition.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Structural and functional basis of cyclooxygenase inhibition.
@en
type
label
Structural and functional basis of cyclooxygenase inhibition.
@en
prefLabel
Structural and functional basis of cyclooxygenase inhibition.
@en
P356
P1476
Structural and functional basis of cyclooxygenase inhibition.
@en
P2093
Anna L Blobaum
Lawrence J Marnett
P304
P356
10.1021/JM0613166
P407
P577
2007-03-07T00:00:00Z